Silo Wellness to Create a Psychedelic Pharmaceutical Manufacturing and Research Portfolio with Proposed Acquisition of Dyscovry Science Psychedelics Investing
Albert Labs: Treating Cancer-Related Distress With Psilocybin-Based Medication Psychedelics Investing
Optimi Health: Natural Psychedelic Wellness Alternatives Capitalizing Diverse Revenue Streams Psychedelics Investing
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc. Psychedelics Investing
Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101 Pharmaceutical Investing
Awakn Life Sciences Files Patent Cooperation Treaty Application for the Treatment of Behavioral Addictions Company News
Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation Psychedelics Investing
Nirvana Life Sciences Announces Partner Symeres Can Produce High Volume Controlled Substances Psychedelics Investing
Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for 'The Investor Hotseat' via Live Stream on May 26th Company News
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting Psychedelics Investing
